Community-acquired Coinfection in Coronavirus Disease 2019: A Retrospective Observational Experience.
retrospective_cohort · Level III
Where this comes from
- Record sourced from PubMed, PMID 32604413.
- Also identified by DOI 10.1093/cid/ciaa902 and PMC identifier 7337635.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Community-acquired coinfection in coronavirus disease 2019 (COVID-19) is not well defined. Current literature describes coinfection in 0-40% of COVID-19 patients. In this retrospective report, coinfection was identified in 3.7% of patients and 41% of patients admitted to intensive care (P < .005). Despite infrequent coinfection, antibiotics were used in 69% of patients.
Medical subject headings
- COVID-19
- Coinfection